288385-88-6Relevant articles and documents
Preparation method of 4-fluoro-5-hydroxy-2-methyl-1H-indole
-
, (2019/11/13)
The invention provides a preparation method of 4-fluoro-5-hydroxy-2-methyl-1H-indole. The preparation method comprises the steps that 2-fluoro-3-halo-6-nitrotoluene is used as a raw material and subjected to a substitution reaction with alcohol to prepare 2-fluoro-3-GO substituent-6-nitrotoluene, then 2-fluoro-3-GO substituent-6-nitrotoluene is subjected to a condensation reaction with trimethyl orthoacetate or triethyl orthoacetate to obtain 1-(2-fluoro-3-GO substituent-6-nitrophenyl)-2-alkoxy propylene, and then 1-(2-fluoro-3-GO substituent-6-nitrophenyl)-2-alkoxy propylene is further subjected to a reduction-cyclization reaction to obtain 4-fluoro-5-hydroxy-2-methyl-1H-indole. The preparation method is safe and green, simple in operation, low in cost, high in selectivity and high in yield and purity of a final product.
Commercial synthesis of a pyrrolotriazine-fluoroindole intermediate to brivanib alaninate: Process development directed toward impurity control
Pesti, Jaan A.,LaPorte, Thomas,Thornton, John E.,Spangler, Lori,Buono, Frederic,Crispino, Gerard,Gibson, Frank,Lobben, Paul,Papaioannou, Christos G.
, p. 89 - 102 (2014/05/20)
The development of a practical, commercial process for the preparation of 4-fluoro-2-methyl-indol-5-ol and its subsequent coupling with a pyrrolotriazine to form an advanced intermediate of the oncology therapy brivanib alaninate is described. A key aspect is the multikilogram-scale preparation of the fluoroindole intermediate from trifluoronitrobenzene and the subsequent coupling while achieving impurity minimalization. As brivanib alaninate is a high-dose drug, the synthesis of highquality API with low levels of impurities is critical.
CHEMICAL PROCESS
-
Page/Page column 41-42, (2008/12/05)
The present invention relates to chemical processes for the manufacture of certain quinazoline derivatives, or pharmaceutically acceptable salts thereof. The invention also relates to processes for the manufacture of certain intermediates useful in the manufacture of the quinazoline derivatives and to processes for the manufacture of the quinazoline derivatives utilising said intermediates. In particular, the present invention relates to chemical processes and intermediates useful in the manufacture of the compound 4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline.